IL29925A - Tetanus vaccine and process for preparing it - Google Patents

Tetanus vaccine and process for preparing it

Info

Publication number
IL29925A
IL29925A IL29925A IL2992568A IL29925A IL 29925 A IL29925 A IL 29925A IL 29925 A IL29925 A IL 29925A IL 2992568 A IL2992568 A IL 2992568A IL 29925 A IL29925 A IL 29925A
Authority
IL
Israel
Prior art keywords
tetanus
vaccine
urea
toxoid
present
Prior art date
Application number
IL29925A
Other languages
English (en)
Other versions
IL29925A0 (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IL29925A0 publication Critical patent/IL29925A0/xx
Publication of IL29925A publication Critical patent/IL29925A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL29925A 1967-05-06 1968-05-03 Tetanus vaccine and process for preparing it IL29925A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1967B0092391 DE1617344B2 (de) 1967-05-06 1967-05-06 Verfahren zur herstellung eines tetanus-impfstoffes

Publications (2)

Publication Number Publication Date
IL29925A0 IL29925A0 (en) 1968-07-25
IL29925A true IL29925A (en) 1972-05-30

Family

ID=6986370

Family Applications (1)

Application Number Title Priority Date Filing Date
IL29925A IL29925A (en) 1967-05-06 1968-05-03 Tetanus vaccine and process for preparing it

Country Status (16)

Country Link
US (1) US3542920A (xx)
AT (1) AT277460B (xx)
BE (1) BE714696A (xx)
CH (1) CH513653A (xx)
DE (1) DE1617344B2 (xx)
DK (1) DK119939B (xx)
ES (1) ES353533A1 (xx)
FI (1) FI45765C (xx)
FR (1) FR7913M (xx)
GB (1) GB1229988A (xx)
IE (1) IE32044B1 (xx)
IL (1) IL29925A (xx)
LU (1) LU56019A1 (xx)
NL (1) NL157803B (xx)
NO (1) NO125455B (xx)
SE (1) SE341984B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2340911A1 (de) * 1973-08-13 1975-05-07 Behringwerke Ag Tetanus-antigen und verfahren zu seiner herstellung
DE2355094C3 (de) * 1973-11-03 1979-05-23 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tetanus-Impfstoffs
DE2510987C2 (de) * 1974-10-29 1983-03-24 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tetanusimpfstoffes
DE2457047C3 (de) * 1974-12-03 1979-10-31 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe
EP0593176A3 (en) * 1992-09-28 1995-03-01 Wisconsin Alumni Res Found Pharmaceutical compositions containing botulinum toxin and method of manufacture.

Also Published As

Publication number Publication date
FR7913M (xx) 1970-05-11
NL157803B (nl) 1978-09-15
AT277460B (de) 1969-12-29
FI45765C (fi) 1972-09-11
BE714696A (xx) 1968-11-06
CH513653A (de) 1971-10-15
IE32044L (en) 1968-11-06
IL29925A0 (en) 1968-07-25
DE1617344B2 (de) 1976-04-08
DE1617344A1 (de) 1971-03-25
NO125455B (xx) 1972-09-11
DK119939B (da) 1971-03-15
SE341984B (xx) 1972-01-24
GB1229988A (xx) 1971-04-28
ES353533A1 (es) 1970-01-16
NL6806143A (xx) 1968-11-07
LU56019A1 (xx) 1970-01-13
US3542920A (en) 1970-11-24
FI45765B (xx) 1972-05-31
IE32044B1 (en) 1973-03-21

Similar Documents

Publication Publication Date Title
Schneerson et al. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.
Jansen The toxic antigenic factors produced by Clostridium botulinum types C and D
EP0008969B1 (en) Vaccine and method of making
US4324887A (en) Type II group B Streptococci polysaccharide
DE69922990T2 (de) Herstellungsverfahren von festphasekonjugateimpfstoffen
Watson et al. Studies on Infection with Bacillus anthracis: III. Chemical and Immunological Properties of the Protective Antigen in Crude Extracts of Skin Lesions of B. anthraci
CA1123734A (en) E. coli enterotoxin vaccine for veterinary and human use
US4402939A (en) Vaccinating glycopeptidic antigenic fraction with a very high level of immunogenicity, isolated from cultures of pathogenic germs, processes for isolating said fraction and vaccines containing said fraction
US3674863A (en) Polyvalent immunizing agents and methods for their production
IL29925A (en) Tetanus vaccine and process for preparing it
Quinn et al. Antigenicity of hyaluronic acid.
US4367222A (en) Immune globulin specific to Group B streptococci
IE42760B1 (en) Derivatives of the tetanus toxin, process for their preparation and agents containing them
US4356263A (en) Method of making a polysaccharide vaccine
US4367223A (en) Vaccine against Group B streptococci
US4367221A (en) Immunization against Group B streptococci
Luecke et al. Enhancement by endotoxin of the primary antibody response to bovine serum albumin in chickens
Lee et al. Pneumococcal neuraminidase
Whang et al. Differential effects on immunogenicity and antigenicity of heat, freezing and alkali treatment of bacterial antigens
Enders et al. An immunological study of the A substance or acetyl polysaccharide of pneumococcus type I
Pillemer et al. Immunochemistry of Toxins and Toxoids: IV. The Preparation of Purified Diphtherial Toxoid for Clinical Use
Johnson et al. The immunological properties of alkali-treated proteins
Heidelberger et al. Absence of a prosthetic group in a type-specific polysaccharide of pneumococcus
Seal et al. Studies on the purification of alum-precipitated diphtheria toxoid
Dingle et al. The isolation and properties of the specific polysaccharide of type b Hemophilus influenzae